Go to the answer
Immune peptide Words for a care conversation Bring questions
Words and names
Peptide
Thymosin alpha-1
LL-37
Approval
Compounding
Withdrawn requests
Research labels
A care conversation
Where care begins
Telehealth
License checks
Questions to bring
Before a decision
Evidence questions
The full bill
Coverage words
Reactions
Offers to pause over
Source guide
Immune-peptide terms and care questions
Where can I read the source?
Source note
Use the short note beside a chapter to find the source behind its answer.
Which source answers which question?
Pick the question the claim raises. Product records, advice on how doctors should provide care, license records, and medicine reports answer different questions.
For a proposed benefit, ask to see a study in people with the health condition being discussed. For a cost, request the written quote for that care.
What is the difference between a rule and guidance?
The boards overseeing doctors have a national organization named the Federation of State Medical Boards. It publishes advice on care. Each state’s rules decide what doctors must do by law.
State rules checked September 26, 2026.
Open the relevant source when checking a claim about a particular treatment.
Check a product claim
Medicines made to order: FDA questions and answers
FDA concerns and ingredient requests that were taken back
What an FDA product code can tell you
Look up the names
Find the state medical board
Use FDA’s state pharmacy search links
US health department: where practice needs permission
Read the care guidance
The group of state medical boards’ advice on online care
Advice on treatment menus and follow-up questions
Find the problem-reporting pages
MedWatch: reporting a medicine problem
MedlinePlus on severe allergic reactions
FDA explains the limits of event reports
Read the next topic.
Start here
Immunepeptide.com helps you untangle care questions as a guide, and runs neither a clinic nor a medicine shop.
Source guide Questions to bring Start again